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Abstract
Background: Exclusive breastfeeding for 6 months is assumed to ensure adequate micronutrients for term infants.
Our objective was to investigate the effects of prolonged breastfeeding on B vitamin status and neurodevelopment
in 80 infants with subnormal birth weights (2000-3000 g) and examine if cobalamin supplementation may benefit
motor function in infants who developed biochemical signs of impaired cobalamin function (total homocysteine
(tHcy) > 6.5 μmol/L) at 6 months.
Methods: Levels of cobalamin, folate, riboflavin and pyridoxal 5´-phosphate, and the metabolic markers tHcy and
methylmalonic acid (MMA), were determined at 6 weeks, 4 and 6 months (n = 80/68/66). Neurodevelopment was
assessed with the Alberta Infants Motor Scale (AIMS) and the parental questionnaire Ages and Stages (ASQ) at
6 months.
At 6 months, 32 of 36 infants with tHcy > 6.5 μmol/L were enrolled in a double blind randomized controlled trial to
receive 400 μg hydroxycobalamin intramuscularly (n = 16) or sham injection (n = 16). Biochemical status and
neurodevelopment were evaluated after one month.
Results: Except for folate, infants who were exclusively breastfed for >1 month had lower B vitamin levels at all
assessments and higher tHcy and MMA levels at 4 and 6 months. At 6 months, these infants had lower AIMS scores
(p = 0.03) and ASQ gross motor scores (p = 0.01).
Compared to the placebo group, cobalamin treatment resulted in a decrease in plasma tHcy (p < 0.001) and MMA
(p = 0.001) levels and a larger increase in AIMS (p = 0.02) and ASQ gross motor scores (p = 0.03).
Conclusions: The findings suggest that prolonged exclusive breastfeeding may not provide sufficient B vitamins for
small infants, and that this may have a negative effect on early gross motor development. In infants with mild
cobalamin deficiency at 6 months, cobalamin treatment significantly improvement cobalamin status and motor
function, suggesting that the observed impairment in motor function associated with long-term exclusive
breastfeeding, may be due to cobalamin deficiency.
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Background
Infant micronutrient status depends on gestational age
(GA), birth weight (BW), and maternal micronutrient
status during pregnancy and after delivery for infants
who are breastfed [1, 2]. For infants born at term with
an appropriate weight for GA (AGA), exclusive breast-
feeding is believed to ensure an adequate supply of
micronutrients during the first 6 months [3], whereas
iron, folic acid or multivitamin supplementations are
usually given to infants with a BW below 2500 g (g)
[4, 5]. Breast milk is important for the infant, but it is
however, not a complete food, as it is low in vitamins
K and D [6, 7]. Vitamin K injections to neonates and a
minimum daily intake of 400 IU (10 μg) of vitamin D
beginning soon after birth are therefore recommended
by many countries [8–10]. There have also been
concerns about low levels of other vitamins in breast
milk, namely vitamin A, vitamin B2 (riboflavin), vita-
min B6 and vitamin B12 (cobalamin) [1, 11, 12], but
routine supplementation of these vitamins to breastfed
infants of under-nourished mothers has not been
implemented [1, 13].
As formula is supplemented with several B vitamins,
deficiency is uncommon in formulafed infants [14, 15].
Folate levels are reported to be high in breast milk, and
folate deficiency in term born AGA breastfed infants is
uncommon [16]. There are few data on the prevalence
of vitamin B2 and B6 deficiency among young infants,
but studies in both low-income and high-income coun-
tries have documented a rather high incidence of
deficiency of both vitamins among pregnant and lactat-
ing women [17, 18]. Total cobalamin concentration in
human milk falls progressively during the lactation
period [12, 19], and in exclusively breastfed term infants
with an adequate birth weight, a biochemical profile
indicative of impaired vitamin B12 status has been
reported to be common from 4 months [12, 20]
An adequate micronutrient status is important to support
optimal growth and development during infancy [21]. In a
recent intervention study, cobalamin supplementation
resulted in biochemical evidence of cobalamin repletion
and improvement in motor function and regurgitations in
term infants up to the age of 8 months, demonstrating that
an adequate cobalamin status is important for a rapidly
developing nervous system [22]. Other micronutrients,
including iron and zinc, have also been shown to play an
important role in infant motor development [23].
Low BW is a known risk factor for both developmental
delays and lower stores of several micronutrients [24],
which in turn may affect gross motor development [25, 26].
We investigated B vitamin status during the first 6 months
of life in infants with a subnormal BW (2000-3000 g), in
relation to nutrition, i.e. exclusive breastfeeding for 0–1
month or ≥ 1 month. The association between gross motor
development, nutrition and B vitamin status was assessed
at 6 months. Infants with biochemical signs of cobalamin
deficiency at 6 months were included in a randomized
cobalamin intervention study, and biochemical status and
motor development were evaluated after one month.
Methods
Study population and design
Between December 2008 and April 2010, 97 healthy
infants with a BW 2000-3000 g and their mothers were
consecutively recruited at the Department of Obstetrics
and Gynecology, Haukeland University Hospital, Bergen,
Norway. Determination of gestational age (GA) was
based on ultrasonography at 17–18 weeks’ gestation and
small for gestational age (SGA) was defined as BW less
than the 10th percentile for GA according to recently
updated growth charts for Norwegian infants [27].
The infants and their mothers were invited back for
investigation at 6 weeks, 4 months and 6 months. At
each visit the infants’ growth parameters were measured,
a questionnaire on infant and maternal nutrition and
vitamin supplementation was completed and blood
samples were collected from the infant and the mother.
At 6 months, infant neurodevelopment was assessed. In
infants, cobalamin is the main determinant of plasma
tHcy [2, 28] and a plasma tHcy level of 6.5 μmol/L was
chosen as a cut-off for defining impaired cobalamin
function [29]. Infants with a tHcy level >6.5 μmol/L at
6 months were invited to a double blind randomized
controlled cobalamin intervention study, and biochem-
ical status and motor development were evaluated after
one month.
All infants received sugar water for pain relief during
blood sampling and during injection for those included in
the intervention study [30]. The Regional Committee for
Medical and Health Research Ethics West granted ethical
approval of the protocol, and the mothers gave written, in-
formed consent. An additional written, informed consent
was given by the mothers included in the intervention trial.
The trial is registered with ClinicalTrials.gov, number
NCT0 1201005.
Nutrition
According to Norwegian recommendations all infants
receive vitamin D (10 μg per day) as cod liver oil or
vitamin D drops from 6 weeks of age [31]. Infants with
a BW ≤ 2500 g also receive a multivitamin supplement
for the first 3 weeks after being discharged from the
hospital, iron supplements from 6 weeks to 1 year and
folic acid from 3 days to 3 months of age. In this study
multivitamins were provided as Multibionta, (Merck
Selbstmedikation GmbH, Darmstadt, Germany), iron as
ferrous fumarate mixture, (Nycomed Pharma AS,
Asker, Norway), 9 mg daily from 6 weeks to 6 months,
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and 18 mg daily to 12 months of age, and folic acid
(Apotek, Oslo, Norway), 0.1 mg daily.
Infant nutrition was recorded as exclusive breastfeeding
or mixed feeding, which included breastfeeding combined
with infant formula, exclusive infant formula feeding or ei-
ther of these combined with cereals or solid foods. Infants
who were never breastfed or exclusively breastfed for less
than 1 month were categorized as formula fed and infants
who were exclusively breastfed for more than 1 month
were categorized as breastfed. Months of breastfeeding
was also used as a continuous variable. It was recom-
mended that solid food, usually starting with infant
cereals, was introduced at 6 months of age. The different
cereals contained 3–10 mg iron, 15–45 μg folic acid and
0.09–0.3 mg vitamin B6 per 100 g powder. The various
formulas contained 0.41–1.22 mg iron, 0.06–0.16 mg ribo-
flavin , 0.02–0.05 mg vitamin B6 , 0.09–0.24 μg cobalamin
and 6–15 μg folic acid per 100 ml prepared milk.
The official guideline in Norway is to take a daily folic
acid supplement of 0.4 mg from 1 month before and
throughout the first 2–3 months of pregnancy; however,
only 10% follow this recommendation [32]. Approximately
80 % of the folic acid users report taking an additional
micronutrient supplements during the first trimester [33].
Neurodevelopmental assessment
At 6 months the infants underwent a pediatric examin-
ation and neurodevelopmental evaluation by one
pediatrician (IT), using the Alberta Infants Motor Scale
(AIMS) test [34] and the parental questionnaire Ages
and Stages Questionnaire (ASQ) [35].
AIMS
This is a norm-referenced observational tool designed
for evaluating gross motor development in infants from
birth to 18 months [36]. Assessment is based on free
observation of the child in different positions (prone,
supine, sitting and standing) according to the age of the
child. The obtained score, 0 to 60 points, is converted to
a normative age-dependent percentile rank (5th to 90th
percentile). A score below the 10th percentile is classified
as possibly delayed motor development [36].
All infants were videotaped during the AIMS test. All
scores were revised based on the videotapes, without
access to clinical data, after the study was completed.
The AIMS test was not possible to obtain for all infants
(missing n = 5), because the infant was sleepy or
distressed.
ASQ
To assess neurodevelopment, the Norwegian version of
the 6-month form of ASQ was used. This is a validated
parent-completed developmental screening tool with a
high sensitivity and specificity to detect developmental
delay [37, 38]. ASQ covers 5 developmental domains, i.e.
communication, gross motor function, fine motor func-
tion, personal-social functioning and problem solving,
and each domain has 6 questions on the developmental
milestones. The parents evaluate whether the child has
achieved a milestone (yes, 10 points), has partly achieved
the milestone (sometimes, 5 points) or has not yet
achieved the milestone (no, 0 points). Sums of each do-
main scores were calculated for every infant.
Cobalamin intervention
At 6 months, infants with impaired cobalamin function
(tHcy level >6.5 μmol/L) were invited to participate in
an intervention study. Eligible infants were assigned by
block randomization (envelopes, 10/10) to receive either
an intramuscular injection of 400 μg hydroxycobalamin
(Vitamin B12 Depot, Nycomed Pharma, Norway) (co-
balamin group, n = 16), or a sham injection, i.e. the skin
was punctured by a needle connected to a syringe (pla-
cebo group, n = 16). These procedures were performed
by one pediatrician (ALBM), and the parents were
blinded to whether their infant received cobalamin or
not (both syringes were wrapped in aluminium foil in
order to hide the content, and the parent was asked to
turn her head away, to prevent her from observing
whether the syringe was activated). Assignment to co-
balamin and placebo group was also blinded to the
pediatrician (IT) who performed all the clinical and de-
velopmental assessments, and to the laboratory
personnel. All infants were scheduled for follow-up one
month after the first examination and this included
blood tests, AIMS evaluation (IT) and maternal ques-
tionnaire concerning nutrition, growth and ASQ.
Blood sampling and analyses
Blood samples from the infants and the mothers were
obtained by antecubital venipuncture and collected into
EDTA Vacutainer Tubes (Becton Dickinson) for separ-
ation of plasma and in Vacutainer Tubes without addi-
tives (Becton Dickinson) for separation of serum. Blood
samples for preparation of EDTA-plasma were placed in
ice water, and plasma was separated within 4 h. The
samples were stored at –80 °C until analysis. Plasma
levels of total homocysteine (tHcy) and methylmalonic
acid (MMA) were assayed using a (GC-MS) method
based on methylchloroformate derivatization [39].
Serum cobalamin was determined by a Lactobacillus
leichmannii microbiological assay [40], serum folate by a
Lactobacillus casei microbiological assay [41] whereas
plasma levels of riboflavin and pyridoxal 5´-phosphate
(PLP, the active form of vitamin B6) were analyzed using
an LC-MS/MS assay [42]. A complete set of vitamin and
metabolites was not available for all infants at all time
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points. Analyses of vitamins and biomarkers were
carried out at BEVITAL AS (www.bevital.no).
Statistical analysis
Results are presented as median and interquartile range
(IQR) and mean and standard deviation. Medians were
compared by Mann-Whitney U test, and means with
Student’s t-test. Differences in categorical variables were
tested with the Chi-square test.
Multiple linear regression models were used to assess
the relation of AIMS scores at 6 months with gender,
SGA, weight at 6 months, folic acid and iron supple-
mentation, number of months with exclusive breastfeed-
ing and maternal education.
Graphical illustration of the dose-response relationship
between months of exclusive breastfeeding versus con-
centrations of cobalamin, folate, PLP, riboflavin, tHcy
and MMA levels at 6 months and between AIMS score
and tHcy and MMA levels at 6 months were obtained
by generalized additive models (GAM). The models were
adjusted for folic acid and iron supplementation (i.e. for
infants with BW ≤ 2500 g).
The calculation of the sample size for the intervention
study was based on data from our previous cobalamin
intervention study in infants below 8 months [22]. A cal-
culated sample size of 36; i.e. 18 in each group, would
give the study a statistical power of more than 80 % to
detect a 1.9 difference in AIMS increment score at a 5 %
significance level.
GAMs were computed using the mgcv-package (version
1.4–1) in R (The R Foundation for Statistical Computing,
version 2.8.1), and the SPSS statistical package (version 18)
was used for the remaining statistical analyses. Two-sided




Of the 97 infant-mother dyads initially recruited at birth,
80 infants (including 8 pairs of twins and 1 single twin)
returned at 6 weeks, and were included in either the
formula fed group (n = 32, 40 %) or the breastfed group
(n = 48, 48 %). The formula fed group comprised infants
who were never breastfed (n = 27) and infants who were
exclusively breastfed for less than 1 month (n = 5),
whereas the breastfed group included infants who were
exclusively breastfed for more than 1 month. Mean GA
was 37 weeks (SD 1.8), 41 % were premature, and 33 %
were SGA. Apart from a higher percentage of twins in
the formula fed group, there were no differences in in-
fant characteristics between the formula fed and breast-
fed infants (Table 1).
At 4 months, 12 infants were lost to follow-up (8
from the breastfed group and 4 from the formula fed
Table 1 Characteristics of infants and mothers, growth and








Number at inclusion 32 48
Number at 6 months 26 40
Gender (M) [n (%)] 13 (50) 20 (50) 1
Birth weight (g) 2458 ± 294b 2561 ± 224 0,12
Gestational age (weeks) 36.9 (1.9) 37.3 (1.8) 0,42
Premature [n (%)] 10 (39) 16 (40) 0,90
SGA [n (%)] 7 (30) 13 (33) 0,63
Twins [n (%)] 10 (39) 4 (10) 0,006
Exclusive breastfeed
(months)
0 (0)c 5 (3.4, 5.4) 0,02
Folate and iron
supplementation [n (%)]d
16 (62) 14 (35) 0,03
Multivitamin
supplementation [n (%)]e
11 (42) 12 (30) 0,31
Characteristics of mothers
BMI prior to pregnancy
(kg/m2)
23.7 (4.0) 22.5 (3.3) 0.19
Higher education
[n (%)]f
10 (42) 28 (70) 0,03
Plasma MMA μmol/l
at 6 months
0.15 (0.13–0.18) 0.18 (0.16–0.21) 0.01
Plasma tHcy
μmol/l at 6 months
7.17 (5.91–9.69) 7.86 (7.05–10.95) 0.10
Growth and neurodevelopment at 6 month
Weight (g) 7256 ± 646 7019 ± 894 0,25
Weight gain (g)g 4797 ± 750 4458 ± 907 0,10
AIMS (score) 24 (22, 27) 21 (18, 25) 0,03
AIMS (percentile) 50–75 (25–50,
75)
25–50 (25, 50) 0,01
ASQ, communication
(score)
48 (40, 50) 45 (35, 50) 0.35
ASQ, gross motor (score) 40 (35, 49) 35 (25, 40) 0.01
ASQ, fine motor (score) 50 (36, 60) 35 (30, 50) 0.06
ASQ, problem solving
(score)
50 (50, 60) 50 (40, 58) 0.22
ASQ, personal-social
(score)
45 (35, 50) 45 (35, 53) 0.66
aProportions were compared by chi-square test. Means were compared by
student’s t-test. Medians were compared by mann-Whitney U test
bMean ± SD (all such values)
cMedian; IQRs in parentheses (variable that was not normally distributed) (all
such values)
dFolic acid supplementation 0.1 mg daily from day 3 to 3 months
eMultivitamin supplementation the first 3 weeks of life
fMinimum 3 years of college or university education (one missing in
each group)
gWeight gain from birth to 6 months
SGA Small for gestational age < 10percentila, AIMS Alberta Infant Motor Scale,
AIMS was missing for 5 infants, ASQ Ages and stages questionnaires, ASQ was
missing for 5 infants
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group) and at 6 months additional 2 infants were lost
to follow-up in the formula fed group. These 14 in-
fants showed no significant differences in baseline
characteristics compared to the study group at 6 weeks
(all p > 0.21).
As recommended, all infants received cod liver oil or
other vitamin D supplementation from age 6 weeks and
infants with BW ≤ 2500 g (n = 36, 45 %) also received
iron (100 %), folic acid (100 %) and multivitamin supple-
ment (78 %).
Mothers
A higher proportion of the breastfeeding mothers had
higher education and they tended to have a lower pre
pregnancy body mass index (Table 1). Age, parity and
number of previous pregnancies were the same for the
groups.
Daily use of multivitamin supplement for a shorter or
longer period was reported by 38 % of the mothers during
pregnancy, and by 28 % postpartum up to 6 months, with
no significant differences between the groups (p > 0.29).
Apart from a higher MMA level at 6 months in the breast-
feeding compared to the formula feeding mothers
(Table 1), no significant differences were observed in ma-
ternal B vitamin status between the two groups (p > 0.10).
During follow-up, the mothers had a fairly stable vitamin
B status except for PLP, which increased from 6 weeks to
6 months. Maternal PLP and riboflavin levels were consid-
erably lower than in the infants.
Infant vitamin status in relation to breastfeeding practice
At 6 months, duration of exclusive breastfeeding in
months from birth was inversely associated with infant
B vitamin levels, i.e. cobalamin (r = -0.55, p < 0.001), PLP
(r = -0.53, p < 0.001), riboflavin (r = -0.57, p < 0.001), and
positively associated with the metabolic markers, tHcy
(r = 0.47, p < 0.001) and MMA (r = 0.55, p < 0.001). No
association was observed between duration of exclusive
breastfeeding and folate level (r =0.01, p = 0.97).
Although cobalamin, PLP and riboflavin levels in-
creased somewhat in the breastfed infants from 6 weeks
to 6 months, the formula fed infants had at all assess-
ments significantly higher levels of these vitamins and at
4 and 6 months also significantly lower levels of the
metabolic markers tHcy and MMA compared to breast-
fed infants (Table 2). The groups did not differ in folate
levels at any time point (Table 2).
In a multiple linear regression model, which in-
cluded gender, infant weight at 6 months, and iron
and folate supplementation (i.e. for infants with BW ≤
2500 g), the strongest determinant of infant B vitamin
status at 6 months was duration (months) of exclusive
breastfeeding (Table 3). B vitamin status at 6 months
showed a linear, inverse relationship with duration
Table 2 Vitamins and metabolites in infants aged 6 weeks,
4 months and 6 months according to nutritiona




















372 (294, 444) 234 (158, 321) <0.001
At 4
months
476 (404, 573) 281 (224, 423) <0.001
At 6
months








27.2 (21.1, 119.9) 0.09
At 4
months
61.4 (44.0, 84.5) 64.4 (41.8, 85.6) 0.96
At 6
months






274 (201, 337) 79 (42, 132) <0.001
At 4
months
230 (155, 281) 135 (88, 161) <0.001
At 6
months







62.2 (43.1, 84.1) 16.3 (13.8, 22.6) <0.001
At 4
months
36.3 (21.0, 47.2) 12.5 (9.8, 17.1) <0.001
At 6
months






7.24 (5.91, 8.42) 7.44 (6.31, 9.07) 0.36
At 4
months
5.90 (5.14, 7.26) 8.11 (6.40, 10.32) <0.001
At 6
months






0.61 (0.38, 1.14) 0.54 (0.28, 1.87) 0.59
At 4
months
0.22 (0.20, 0.39) 0.50 (0.21, 1.32) 0.01
At 6
months
0.19 (0.16, 0.36) 0.59 (0.33, 1.20) <0.001
Pe <0.001 0.29
aAll values are medians, (IQR)
bMann-Whitney U
c4 months: One blood sample missing 0–1 month, one missing for cobalamin
and folate >1 month
d6 months: Four missing for PLP and riboflavin >1 month
eFriedman test
PLP Pyridoxal 5´-phosphate, tHcy total homocysteine, MMA Metylmalonic acid
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(months) of exclusive breastfeeding, as shown by
GAM (Fig. 1a).
When comparing infants with BW ≤ 2500 g and BW
2501-3000 g, we observed no differences in B vitamin
levels and the metabolic markers at 4 or 6 months (p >
0.13) except for folate at 6 weeks and 4 months, which
was higher in infants BW ≤ 2500 g, who had been sup-
plemented with folic acid (p < 0.001).
Neurodevelopment in relation to breastfeeding practice
and B vitamin status
AIMS data were available for 61 of the 66 (92 %) infants
at 6 months. Of the 5 infants with missing data, 3 came
from the formula fed and 2 from the breastfed group.
The formula fed infants had a significantly higher me-
dian AIMS score than the breastfed infants (Table 1).
In the breastfed group 25/38 (66 %) infants scored
below the 50th percentile and 8/38 (21 %) below the 10th
percentile, i.e. classified as possibly delayed motor devel-
opment, compared to 9/23 (39 %, p = 0.04) and 3/23
(13 %, p = 0.43) in the formula fed group.
Duration of exclusive breastfeeding was a significant
negative predictor of AIMS score in a multiple linear re-
gression model adjusted for gender, SGA, infant weight at
6 months, maternal education and folate and iron supple-
mentations (B = -0.5; (95 % CI; -0.9 - -0.03, p = 0.04) per
month of exclusive breastfeeding). The dose-response re-
duction in AIMS score with increasing levels of tHcy and
MMA is visualized by GAM curves in Fig. 1b.
ASQ data were available for 61 of the 66 (92 %) infants
at 6 months (missing data for 2 infants in the formula
fed and for 3 infants in the breastfed group). The breast-
fed infants had a significantly lower median gross motor
score (p = 0.01) and the median fine motor score showed
a similar trend (p = 0.06). No significant differences were
observed for communication, personal-social functioning
and problem solving skills (p > 0.09) (Table 1).
Cobalamin intervention
At 6 months, 36 (45 %) of the 66 infants had plasma
tHcy > 6.5 μmol/L and were invited to participate in the
intervention study. Of these, 32 infants accepted and
were included (cobalamin group, n = 16 and placebo
group, n = 16). All, but one infant (from the placebo
group), came back for assessment after one month.
At inclusion, there were no significant differences be-
tween the cobalamin and the placebo group for infant
characteristics (growth parameters at birth and 6 months,
GA, SGA and twin status, use of vitamins and iron, AIMS
score and ASQ scores) or maternal characteristics (age,
pre pregnancy BMI and parity) (p > 0.06). There were
however, more girls in the cobalamin group (11/16) than
in the placebo group (4/16) (p = 0.01) and infants in the
cobalamin group were exclusively breastfed for a longer
period (median 5 months (IQR 3, 6)) compared to the pla-
cebo group (3 months (0, 5), p = 0.03). This was reflected
in significantly higher tHcy levels (median 9.57 μmol/L
(IQR 7.62, 11.61)) in the cobalamin group compared to
the placebo group (7.72 μmol/L (6.91, 8.33), p = 0.02) at
inclusion. No other significant differences in metabolic
parameters were seen (p > 0.16).
The observed changes in cobalamin, tHcy, and MMA
levels from inclusion to follow-up were significantly
greater in the cobalamin compared to the placebo group
(Table 4), while no significant differences between the
two groups were observed for the other vitamins. AIMS
and ASQ scores increased in both groups from inclusion
at age 6 months to follow-up at age 7 months as ex-
pected; however, the median increase in scores for AIMS
and for ASQ gross motor function were significantly
higher for the cobalamin group than the placebo group
(Table 4). There were no significant differences between
the groups for fine motor score, communication,
personal-social functioning or problem solving skills
(p > 0.4). No adverse effects from the cobalamin injec-
tions were reported.
Discussion
In the present study of infants with BW between 2000-
3000 g, those who were mainly formula fed from birth
had significantly higher levels of cobalamin, PLP and ribo-
flavin and lower levels of the metabolic markers, tHcy and
MMA, and a better gross motor development at 6 months
compared to infants who were exclusively breastfed for











B p B p B p B p B p B p
Gender (boys, girls) 25.65 0.67 -3.53 0.55 8.79 0.61 -0.32 0.93 -0.01 0.99 -0.03 0.90
Weightb 33.44 0.23 0.83 0.76 0.61 0.94 3.00 0.09 -0.07 0.80 -0.15 0.15
Exclusive breastfeedingc -44.32 0.001 -0.76 0.53 -17.53 <0.001 -4.16 <0.001 0.55 <0.001 0.12 0.008
aThe regression model contains folic acid and iron supplementations as independent variables, in addition to the parameters listed in the table
bInfant weight at 6 months, quartiles
cExclusive breastfeeding, number of months with exclusive breastfeeding from birth to 6 months
PLP Pyridoxal 5´- phosphate, B: regression coefficient
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more than 1 month, despite the fact that the formula fed
group had more twins and lower maternal educational
level, factors known to be negatively associated with neu-
rodevelopment [43, 44]. Furthermore, vitamin status, as
well as gross motor function, was negatively and linearly
associated with duration of exclusive breastfeeding when
adjusted for possible confounders.
In infants with biochemical signs of mild cobalamin defi-
ciency at 6 months, cobalamin treatment resulted in signifi-
cant improvement in cobalamin status and motor function.
These results indicate that the observed impairment in
motor function associated with long-term exclusive breast-
feeding, may be due to cobalamin deficiency.
Study design and limitations
The first part of this study was observational, known to
have its limitations. However, data were collected pro-
spectively, the participation rate was high throughout
the study and there were no significant differences in in-
fant or maternal characteristics between the two groups
that could explain the differences in clinical outcome.
Evaluation of motor development, a major develop-
mental function in early infancy [36, 45] is challenging
[46]. Infants develop discontinuously, and the age of
achieving gross motor milestones varies substantially
among healthy term infants [47]. The AIMS test is con-
sidered to be among the most reliable tests for assessing
gross motor function [36, 45] and ASQ is a validated
screening tool with high sensitivity and specificity to de-
tect children with developmental delay [38]. It was a
weakness of the study that the examiner was not blinded
to the nutrition of the infants when the infants were first
assessed at 6 months, however, as all AIMS scores were
revised based on the videotape, without access to clinical
data, after the study was completed, potential confounding
was minimized. In the intervention study, both the par-
ents and the examiner were blinded to the intervention
when assessing the infants 1 month after randomization.
The intervention study included 86 % of eligible in-
fants with cobalamin deficiency at 6 months. Apart from
differences in gender and period of exclusive breastfeed-
ing, similar characteristics of the cobalamin and placebo
groups suggest that the randomization was appropriate.
The given dose of 400 μg hydroxycobalamin represents
approximately twice the total amount of cobalamin con-
sidered necessary for the first year of life, based on an
Adequate Intake (AI) for cobalamin [48]. This dosage
has been proven to improve cobalamin status and en-
hance motor development in young infants [22].
B vitamin status and psychomotor development
Gross motor function is a good marker of neurodevelop-
ment in early infancy [45, 49], and is known to be related
to micronutrient status [25, 26]. We have earlier demon-
strated in a randomized, double blind intervention study
that cobalamin supplementation not only improves
(See figure on previous page.)
Fig. 1 a. Dose-response relationship of cobalamin, folate, PLP, riboflavin, tHcy and MMA at 6 months with months of exclusive breastfeeding by
Generalized additive models (GAM), adjusted for gender, infant weight at 6 months and iron and folate supplementation. The solid line shows
the fitted model and the shaded areas indicate 95 % CIs. PLP, pyridoxal 5´phosphate; tHcy, total homocysteine; MMA, methylmalonic acid. b.
Dose-response relationship of tHcy and MMA at 6 months with AIMS scores at 6 months by Generalized Additive Models (GAM), adjusted for
gender, infant weight at 6 months and iron and folate supplementation. The solid line shows the fitted model and the shaded areas indicate
95 % CIs. tHcy, total homocysteine; MMA, methylmalonic acid
Table 4 Change in biochemical status and clinical parameters
















































3.7 (-3.5, 8.4), 3 % <0.32a




5.0 (4.0, 7.0), 23 % 0.02a














Length, cm, (mean (SD)),
%change
2.0 (1.3), 3 % 1.8 (1.1), 3 % 0.81b
Head circumference, cm,
(mean (SD)), %change
0.8 (0.7), 2 % 0.8 (0.4), 2 % 0.89b
aMedians were compared by Mann-Whitney U test
bMeans were compared by Student’s t-test
cMissing data for 2 infants in the Cobalamin group and 4 infants in the
Placebo group
PLP Pyridoxal 5´- phosphate, AIMS Alberta Infant Motor Scale, ASQ Ages and
Stages Questionnaires
Torsvik et al. BMC Pediatrics  (2015) 15:218 Page 8 of 11
biochemical measures of cobalamin status, but also motor
development and gastrointestinal symptoms in moderately
cobalamin-deficient infants, an observation that emphasizes
the importance of an adequate cobalamin status for normal
neurodevelopment [22]. In the present study, formula fed
infants had significantly better B vitamin status and higher
median AIMS and ASQ scores compared to the breastfed
infants. We cannot exclude that nutrients other than B vita-
mins, may at least partially, have contributed to the ob-
served differences in clinical outcome. Our study
population consisted of infants born with a suboptimal
BW, and one may assume that they had a higher risk of
micronutrient deficiency compared to infants born AGA
close to term. Motor development was, however, not re-
lated to BW or AGA vs. SGA status. Motor development is
influenced by several factors, like GA, BW, neonatal health
and genetic, cultural and parental sociodemographic factors
[43, 50]. After adjusting for such factors, the associations
between gross motor function and duration of exclusive
breastfeeding remained, suggesting that at least cobalamin
status had a significant effect on gross motor function. The
intervention study confirmed this notion, as our results in-
dicate that the observed impairment in motor function as-
sociated with long-term exclusive breastfeeding is corrected
by cobalamin supplementation.
Prolonged exclusive breastfeeding and adequate
micronutrient status
With the exception of vitamin D and K, which are sup-
plemented, the World Health Organization (WHO) con-
siders breast milk to be a complete food for the term
infant for the first 6 months of life, a period of rapid
growth and development [51]. Low BW (<2500 g) is a
recognized risk factor for multiple micronutrient defi-
ciencies, although supplementation with only iron and
folic acid are commonly recommended [52–54].
We observed a higher MMA level, despite a similar
cobalamin level, indicative of inadequate intracellular co-
balamin status, in the breastfeeding compared to the for-
mula feeding mothers at 6 months. Cobalamin levels in
milk correlate with maternal plasma levels [55] and falls
progressively during the lactional period [12, 19]. The
estimated cobalamin intake from breastmilk has been re-
ported to be maximal at 12 weeks, and reduced by 50 %
at 24 weeks [56], which may not be satisfactory given
the crucial role for cobalamin in neurodevelopment [20].
The present study suggests that prolonged exclusive
breastfeeding may not sustain sufficient B vitamin status,
not only for those with a low BW, but also for infants
with a BW in the range 2500–3000 g. Although all B vi-
tamins, except for folate, were lower in breastfed infants
already from 6 weeks, the metabolic markers were
significantly higher from 4 months, suggesting an intra-
cellular B vitamin deficency in exclusively breastfed
infants at this age. As B vitamins are important for de-
velopment, these data suggest that introduction of solid
animal food should start from age 3–4 months.
Conclusion
In this study, duration of exclusive breastfeeding was
associated with lower B vitamin status and poorer
gross motor development at 6 months in infants with
BW 2000-3000 g. In infants with biochemical signs of
mild cobalamin deficiency at 6 months, cobalamin
treatment resulted in significant improvement in
cobalamin status and motor function. These results
indicate that the observed impairment in motor func-
tion associated with long-term exclusive breastfeeding,
may be due to cobalamin deficiency. In order to ob-
tain an adequate cobalamin status to ensure normal
neurodevelopment, we suggest that introduction of
solid animal food should start from age 4 months in
infants with a subnormal BW.
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